Type
. For as long as necessary: examining 30 years of Merck & Co., Inc.’s focus on achieving elimination of onchocerciasis and lymphatic filariasis. International Health [Internet]. 2017;. Available from: http://academic.oup.com/inthealth/advance-article/doi/10.1093/inthealth/ihx038/4653557http://academic.oup.com/inthealth/advance-article-pdf/doi/10.1093/inthealth/ihx038/21949126/ihx038.pdf
Type
. Impact of two follow-up schemes on morbidity management and disability prevention (MMDP) programme for filarial lymphedema in Matara, Sri Lanka. Parasitology international. 2017;.
Type
Notes
<p>People with disabilities are often not able to have a say in decisions that are made that affect them, including in the way that international development is organised, and research is carried out. <a class="ext" href="http://www.cbm.org/" target="_blank">CBM</a> is committed to challenging this situation, believing that people affected by such decisions should have a voice in them, and that they hold a unique form of expertise that can contribute to excellence in research and programming.</p>
Custom 7
<div>
<div>
<div>
<div>
<div>
<div>
<div>Julian Eaton and Muhammad Jidda Assakin</div>
</div>
</div>
</div>
</div>
</div>
</div>
Year of Publication
2017
Publication Language
eng
Citation Key
30828
Type
. Operational issues of lymphatic filariasis elimination program and community acceptance of mass drug administration. Chattagram International Medical College Journal [Internet]. 2016;1(1):7-11. Available from: http://cimch.edu.bd/resources/journal/Article-2.pdf
Type
. Integrated risk mapping and landscape characterisation of lymphatic filariasis and loiasis in South West Nigeria. Parasite epidemiology and control [Internet]. 2018;3(1):21–35. Available from: https://tinyurl.com/ybnnnh8u